Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Update

Aurora Cannabis Inc. (NASDAQ:ACB) saw a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 2,810,000 shares, a growth of 6.8% from the October 15th total of 2,630,000 shares. Based on an average daily volume of 1,030,000 shares, the short-interest ratio is presently 2.7 days. Approximately 5.2% of the company’s shares are short sold.

Hedge Funds Weigh In On Aurora Cannabis

A number of hedge funds have recently added to or reduced their stakes in ACB. Virtu Financial LLC purchased a new position in Aurora Cannabis during the first quarter valued at approximately $727,000. TD Asset Management Inc purchased a new stake in shares of Aurora Cannabis during the 2nd quarter worth $255,000. Headlands Technologies LLC boosted its position in Aurora Cannabis by 98.8% during the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after purchasing an additional 37,269 shares in the last quarter. Mackenzie Financial Corp purchased a new position in Aurora Cannabis in the second quarter valued at about $113,000. Finally, Toronto Dominion Bank raised its holdings in Aurora Cannabis by 34,356.4% in the second quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock worth $88,000 after purchasing an additional 18,896 shares in the last quarter. 47.63% of the stock is currently owned by institutional investors.

Aurora Cannabis Price Performance

Shares of ACB stock opened at $4.20 on Friday. The stock has a 50 day moving average price of $5.52 and a 200 day moving average price of $5.88. The firm has a market capitalization of $230.33 million, a P/E ratio of -5.53 and a beta of 1.87. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.83. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.